381 related articles for article (PubMed ID: 34204940)
1. Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.
Uddin MH; Al-Hallak MN; Philip PA; Mohammad RM; Viola N; Wagner KU; Azmi AS
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204940
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs: novel players in cervical cancer.
Nahand JS; Vandchali NR; Darabi H; Doroudian M; Banafshe HR; Moghoofei M; Babaei F; Salmaninejad A; Mirzaei H
Epigenomics; 2020 Sep; 12(18):1651-1660. PubMed ID: 32957811
[TBL] [Abstract][Full Text] [Related]
5. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients.
Kawamura S; Iinuma H; Wada K; Takahashi K; Minezaki S; Kainuma M; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2019 Feb; 26(2):63-72. PubMed ID: 30561106
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
8. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
10. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.
Chen K; Wang Q; Kornmann M; Tian X; Yang Y
Front Oncol; 2021; 11():644358. PubMed ID: 33718244
[TBL] [Abstract][Full Text] [Related]
11. Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer.
Wang M; Yu F; Ding H; Wang Y; Li P; Wang K
Mol Ther Nucleic Acids; 2019 Jun; 16():791-804. PubMed ID: 31163321
[TBL] [Abstract][Full Text] [Related]
12. microRNA based prognostic biomarkers in pancreatic Cancer.
Guo S; Fesler A; Wang H; Ju J
Biomark Res; 2018; 6():18. PubMed ID: 29942514
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
Wu J; Shen Z
Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402
[TBL] [Abstract][Full Text] [Related]
14. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma.
Gao Z; Jiang W; Zhang S; Li P
Anal Cell Pathol (Amst); 2019; 2019():9419072. PubMed ID: 31583198
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
16. In Situ Exosomal MicroRNA Determination by Target-Triggered SERS and Fe
Jiang S; Li Q; Wang C; Pang Y; Sun Z; Xiao R
ACS Sens; 2021 Mar; 6(3):852-862. PubMed ID: 33555177
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: exosomal microRNAs associated with pancreatic cancer for early detection and prognosis.
Ye H; Wang H; Wang P; Song CH; Wang KJ; Dai LP; Shi JX; Liu XX; Sun CQ; Wang X; Peng Y; Chen XB; Zhang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9351-9361. PubMed ID: 31773694
[TBL] [Abstract][Full Text] [Related]
19. Purification and microRNA profiling of exosomes derived from blood and culture media.
McDonald MK; Capasso KE; Ajit SK
J Vis Exp; 2013 Jun; (76):e50294. PubMed ID: 23792786
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]